Research/Idibell
Four projects of IDIBELL on regeneration and transplantation of organs and tissues, two of which are from Bellvitge University Hospital, have been funded by the TV3 Marathon.
Dr. Joseph M. Grinyó, Head of Nephrology of the HUB, leads the project…
A team of researchers from the UPC and IDIBELL has designed and patented a new system to improve the endoscopic examination of peripheral lung lesions. The novelty offered by the system is that it takes into account the geometry and kinematic…
Manel Esteller, director of strategic projects
The Board of Trustees of IDIBELL has appointed Josep Manuel Menchón as new Scientific Director of the centre. Dr. Menchón is a renowned physician and researcher in the…
The Minister of Health, Boi Ruiz, opened on May 11th the new Laboratory of Metabolism and Cancer of the Institute of Bellvitge Biomedical Research (IDIBELL).The opening ceremony was also attended by the mayor of L’Hospitalet de Llobregat, Nuria Marin, and…
The Hub and the Vicente Ferrer Foundation (VFF) have signed a health collaboration agreement over two years ago
As a result of this institutional relationship, in March 2011, IDIBELL and VFF signed a collaboration that includes a program that offers…
A group of researchers at the University Hospital of Bellvitge and IDIBELL participate in the study of Neurobiological and clinical determinants of second schizophrenia Episodes. Longitudinal study of psychotic first Episodes , which has been financed by the FIS.
It is…
The research group of Dr. Isidro Ferrer, director of the Institute of Neuropathology at the University Hospital of Bellvitge, has initiated two research projects that seek to identify brain changes that are precursors of Alzheimer’s and Parkinson’s diseases.The study of Transcriptome Identification…
Dr. Angel Cequier, clinical director for heart disease in Bellvitge University Hospital, is one of the authors of the article Thromb-Receptor Antagonist in Acute Coronary Syndrom Vorapaxar , published on November 13th in The New England Journal of Medicine .
The study, conducted…
The new drugs against HIV / AIDS appeared after 2007 have led to a reduction in a very significant number of patients who did not respond to the first combined treatment of three or more drugs, as was revealed by…
A multicentre trial of the Spanish hospitals Network for Translational Research in Oncological Gynecology (REDITOG), coordinated by IDIBELL researcher and Head of Gynaecology at the HUB Dr. Jorge Ponce, has validated the use of a genetic test for the early detection of endometrial cancer. The study, which included over 500 patients, was coordinated by Dr. Ponce and Dr. Antonio Gil from the University Hospital Vall d’Hebron.
According…
